Primary Prevention of Cardiovascular Disease at Community Clinics in the State of Sao Paulo, Brazil: Results from the Epidemiological Information Study of Communities
References
- Walli-Attaei M, Joseph P, Rosengren A, Chow CK, Rangarajan S, Lear SA, et al., Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020; 396(10244): 97–109. DOI: 10.1016/S0140-6736(20)30543-2
- Gooding HC, Gidding SS, Moran AE, Redmond N, Allen NB, Bacha F, et al. Challenges and opportunities for the prevention and treatment of cardiovascular disease among young adults: Report from a National Heart, Lung, and Blood Institute working group. J Am Heart Assoc. 2020; 9(19):
e016115 . DOI: 10.1161/JAHA.120.016115 - Chomistek AK, Chiuve SE, Eliassen AH, Mukamal KJ, Willett WC, Rimm EB. Healthy lifestyle in the primordial prevention of cardiovascular disease among young women. J Am Coll Cardiol. 2015; 65: 43–51. DOI: 10.1016/j.jacc.2014.10.024
- Barbaresko J, Rienks J, Nothlings U. Lifestyle indices and cardiovascular disease risk: A meta-analysis. Am J Prev Med. 2018; 55: 555–564. DOI: 10.1016/j.amepre.2018.04.046
- Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, et al. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. Eur J Prev Cardiol. 2021; 28(4): 370–379. DOI: 10.1177/2047487320908698
- Fernandes LC, Bertoldi AD, Barros AJ. Health service use in a population covered by the Estratégia de Saúde da Família (Family Health Strategy). Rev Saude Publica. 2009; 43(4): 595–603. DOI: 10.1590/S0034-89102009005000040
- Précoma DB, Oliveira GMM, Simão AF, Dutra OP, Coelho OR, Izar MCO, et al. Updated cardiovascular prevention guideline of the Brazilian Society of Cardiology – 2019. Arq Bras Cardiol. 2019; 113(4): 787–891. DOI: 10.5935/abc.20190204
- 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140: e596–e646. DOI: 10.1161/CIR.0000000000000678
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–3104. DOI: 10.1093/eurheartj/ehy339
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499–502. DOI: 10.1093/clinchem/18.6.499
- Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune A Neto, et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol. 2017; 109(2Supl.1): 1–76. DOI: 10.5935/abc.20170121
- Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019; 290: 140–205. DOI: 10.1016/j.atherosclerosis.2019.08.014
- International Diabetes Federation. Clinical Guidelines Task Force global guideline for type 2 diabetes. Brussel; 2012.
www.idf.org . (Accessed 20 june 2021). - Authors/Task Force Members:, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2016; 37: 2315–2381. DOI: 10.1093/eurheartj/ehw106
- Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al., 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75(6): 1334–1357. DOI: 10.1161/HYPERTENSIONAHA.120.15026
- Akanbi MO, Carroll AJ, Achenbach C, O’Dwyer LC, Jordan N, Hitsman B, et al. The efficacy of smoking cessation interventions in low- and middle-income countries: A systematic review and meta-analysis. Addiction. 2019; 114(4): 620–635. DOI: 10.1111/add.14518
- Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens. 2014; 32(12): 2285–2295. DOI: 10.1097/HJH.0000000000000378
- SPRINT Research Group, Wright, JT
Jr , Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373(22): 2103–2116. DOI: 10.1056/NEJMoa1511939 - Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet. 2016; 387(10022): 957–967. DOI: 10.1016/S0140-6736(15)01225-8
- Lopes, RD, Barroso WKS, Brandao AA, Barbosa ECD, Malachias, MVB, Gomes, MM, et al. The First Brazilian Registry of Hypertension. Am Heart J. 2018; 205: 154–157. DOI: 10.1016/j.ahj.2018.08.012
- Dixon DL, Sharma G, Sandesara PB, Yang E, Braun LT, Mensah GA, et al. Therapeutic inertia in cardiovascular disease prevention: Time to move the bar. J Am Coll Cardiol. 2019; 74(13): 1728–1731. DOI: 10.1016/j.jacc.2019.08.014
- Nelson AJ, Pagidipati NJ, Aroda VR, Cavender MA, Green JB, Lopes RD, et al. Incorporating SGLT2i and GLP-1RA for cardiovascular and kidney disease risk reduction: Call for action to the cardiology community. Circulation. 2021; 144(1): 74–84. DOI: 10.1161/CIRCULATIONAHA.121.053766
- Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, et al. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): A cluster-randomised controlled trial. Lancet. 2019; 394(10205): 1231–1242. DOI: 10.1016/S0140-6736(19)31949-X
- Mendes ABV, Fittipaldi JAS, Neves RCS, Chacra AR, Moreira ED,
Jr . Prevalence and correlates of inadequate glycaemic control: Results from a nationwide survey in 6,671 adults with diabetes in Brazil. Acta Diabetol. 2010; 47: 137–145. DOI: 10.1007/s00592-009-0138-z - Viana LV, Leitão CB, Kramer CK, Zucatti AT, Jezini, DL, Felício J, et al. Poor glycaemic control in Brazilian patients with type 2 diabetes attending the public healthcare system: A cross-sectional study. BMJ Open. 2013; 3(9):
e003336 . DOI: 10.1136/bmjopen-2013-003336 - Coutinho DF, de Figueiredo, RC, Duncan BB, Schmidt MI, Barreto SM, Diniz MFHS. Association between control of diabetes mellitus and polypharmacy at the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Pharmacoepidemiol Drug Saf. 2021; 30(6): 749–757. DOI: 10.1002/pds.5236
- Banegas JR, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: The EURIKA study. Eur Heart J. 2011; 32: 2143–2152. DOI: 10.1093/eurheartj/ehr080
- Blom DJ, Santos RD, Daclin V, Mercier F, Ruiz AJ, Danchin N; ICLPS study group. The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International Cholesterol Management Practice Study. Eur J Prev Cardiol. 2020; 27(13): 1403–1411. DOI: 10.1177/2047487319871735
- Santos RD, Pereira C, Cesena F, Laurinavicius AG, Tabone, V, Bittencourt MS. Cardiovascular risk misperception and low awareness of familial hypercholesterolemia in individuals with severe hypercholesterolemia. Arq Bras Cardiol. 2021; 116(4): 706–712. DOI: 10.36660/abc.20190516
- Vallejo-Vaz AJ, Robertson M, Catapano AL, Watts GF, Kastelein JJ, Packard CJ, et al. Low-density lipoprotein cholesterol lowering for the primary prevention of cardiovascular disease among men with primary elevations of low-density lipoprotein cholesterol levels of 190 mg/dL or above: Analyses from the WOSCOPS (West of Scotland Coronary Prevention Study) 5-year randomized trial and 20-year observational follow-up. Circulation. 2017; 136: 1878–1891. DOI: 10.1161/CIRCULATIONAHA.117.027966
- World Health Organization. HEARTS: technical package for cardiovascular disease management in primary health care. Geneva: World Health Organization; 2016.
https://www.who.int/cardiovascular_diseases/hearts/Hearts_package.pdf . (Accessed 20 June 2021).
DOI: https://doi.org/10.5334/gh.1203 | Journal eISSN: 2211-8179
Language: English
Submitted on: Oct 7, 2022
Accepted on: Apr 12, 2023
Published on: May 5, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Henrique Andrade R. Fonseca, Maria Cristina O. Izar, Luciano F. Drager, Ibraim M. Pinto, José Francisco K. Saraiva, João Fernando Monteiro Ferreira, Álvaro Avezum, Francisco Antonio Fonseca, Otávio Berwanger, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.